PHARMAWRITE AT THE 13TH ANNUAL HOPA CONFERENCE
March 29 – April 1, 2017
The Hematology/Oncology Pharmacy Association (HOPA) organizes an annual conference for hematology/oncology pharmacy practitioners to educate attendees about emerging research and new treatment regimens, provide clinical updates on treatment of tumor types and new supportive care therapies, and present an overview of common clinical and technical issues in the hematology/oncology clinical setting.
Held this year in Anaheim, CA, the 13th Annual HOPA conference was designed to help pharmacists and pharmacy
researchers, technicians, residents, interns, and administrators specializing in hematology/oncology practice, as well
as associated oncology/hematology professionals, improve the efficiency of healthcare delivery while maintaining or
exceeding the quality of patient care.
Members of PharmaWrite’s Oncology Working Group were in attendance, and we are anxious to share what they learned. Please choose a Topic Summary on the right for a more detailed overview of some of the important presentations and discussions at this year’s conference. To learn more about how PharmaWrite can assist your company, please fill out the form below. |
Topic Summaries
TREATMENT CONSIDERATIONS IN SPECIAL POPULATIONS MANAGEMENT OF YOUNG PATIENTS WITH BREAST CANCER UPDATE ON MANAGEMENT OF APLASTIC ANEMIA BONE-MODIFYING AGENTS FOR THE TREATMENT AND PREVENTION OF SKELETAL-RELATED EVENTS (SRE) AND HYPERCALCEMIA THE CURATIVE POTENTIAL OF HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR SICKLE CELL DISEASE |